New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR) - PubMed (original) (raw)
New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)
K Eeg-Olofsson et al. J Intern Med. 2010 Nov.
Free article
Abstract
Aims: To analyse the association between glycosylated haemoglobin A1c (HbA1c) and cardiovascular disease (CVD) in patients with type 2 diabetes in the Swedish National Diabetes Register (NDR).
Methods: An observational study of 18 334 patients (age 30-79 years, previous CVD in 18%, baseline HbA1c 5.0-10.9%) who were followed for 6 years (mean 5.6 years) from 1997/1998 until 2003.
Results: Hazard ratios per 1% unit increase in baseline or updated mean HbA1c for fatal/nonfatal coronary heart disease (CHD), CVD and total mortality were 1.11-1.13, 1.10-1.11 and 1.09-1.10, respectively (all P < 0.001), adjusted for several risk factors and clinical characteristics in Cox regression. Adjusted 6-year event rates increased with higher baseline or updated mean HbA1c with no J-shaped risk curves, in all patients and also when subgrouping by shorter (mean 3 years) or longer (mean 14 years) diabetes duration, by presence or absence of previous CVD, or by treatment with oral hypoglycaemic agents (OHAs) or insulin. Risk reductions of 20% for CHD and 16% for CVD (P < 0.001) were found in patients with a baseline mean HbA1c of 6.5%, compared to those with a mean level of 7.5%. Compared to OHA-treated patients, insulin-treated patients had an increased risk of total mortality, due almost exclusively to an increased risk of non-CVD mortality, and due less to a weakly significant increased risk of fatal CVD. HbA1c was not associated with non-CVD mortality.
Conclusions: This observational study showed progressively increasing risks of CHD, CVD and total mortality with higher HbA1c, and no risk increase at low HbA1c levels even with longer diabetes duration, previous CVD or treatment with either insulin or OHAs. Patients achieving HbA1c <7% showed benefits for risk reduction.
© 2010 The Association for the Publication of the Journal of Internal Medicine.
Comment in
- Glycemia and cardiovascular diseases in type 2 diabetes.
Skyler JS. Skyler JS. J Intern Med. 2010 Nov;268(5):468-70. doi: 10.1111/j.1365-2796.2010.02276.x. J Intern Med. 2010. PMID: 20964737 No abstract available.
Similar articles
- Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Svensson AM, Gudbjörnsdóttir S, Eliasson B. Eeg-Olofsson K, et al. Diabetes Care. 2010 Jul;33(7):1640-6. doi: 10.2337/dc10-0398. Epub 2010 Apr 27. Diabetes Care. 2010. PMID: 20424222 Free PMC article. - Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
Cederholm J, Zethelius B, Nilsson PM, Eeg-Olofsson K, Eliasson B, Gudbjörnsdottir S; Swedish National Diabetes Register. Cederholm J, et al. Diabetes Res Clin Pract. 2009 Oct;86(1):74-81. doi: 10.1016/j.diabres.2009.07.003. Epub 2009 Aug 12. Diabetes Res Clin Pract. 2009. PMID: 19679369 - Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.
Eeg-Olofsson K, Zethelius B, Gudbjörnsdottir S, Eliasson B, Svensson AM, Cederholm J. Eeg-Olofsson K, et al. Diab Vasc Dis Res. 2016 Jul;13(4):268-77. doi: 10.1177/1479164116637311. Epub 2016 Apr 21. Diab Vasc Dis Res. 2016. PMID: 27190080 - Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis.
Cavero-Redondo I, Peleteiro B, Álvarez-Bueno C, Rodriguez-Artalejo F, Martínez-Vizcaíno V. Cavero-Redondo I, et al. BMJ Open. 2017 Jul 31;7(7):e015949. doi: 10.1136/bmjopen-2017-015949. BMJ Open. 2017. PMID: 28760792 Free PMC article. Review. - The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studies.
Arnold LW, Wang Z. Arnold LW, et al. Rev Diabet Stud. 2014 Summer;11(2):138-52. doi: 10.1900/RDS.2014.11.138. Epub 2014 Aug 10. Rev Diabet Stud. 2014. PMID: 25396402 Free PMC article. Review.
Cited by
- Liraglutide and Robust A1C Reductions Among People With Type 2 Diabetes Requiring Appetite Control: A Review of Two Cases.
Pitts MA, Griggs RH, Hall MR, Tankersley MS, Johnson JL. Pitts MA, et al. Diabetes Spectr. 2024 Spring;37(2):175-179. doi: 10.2337/ds23-0052. Epub 2023 Dec 14. Diabetes Spectr. 2024. PMID: 38756434 No abstract available. - Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights.
Jia G, Bai H, Mather B, Hill MA, Jia G, Sowers JR. Jia G, et al. Int J Mol Sci. 2024 Jan 9;25(2):804. doi: 10.3390/ijms25020804. Int J Mol Sci. 2024. PMID: 38255878 Free PMC article. Review. - Impact of two COVID-19 lockdowns on HbA1c levels in patients with type 2 diabetes and associations with patient characteristics: a multicentre, observational cohort study over three years.
Schäfer I, Tajdar D, Walther L, Bittner L, Lühmann D, Scherer M. Schäfer I, et al. Front Public Health. 2024 Jan 5;11:1272769. doi: 10.3389/fpubh.2023.1272769. eCollection 2023. Front Public Health. 2024. PMID: 38249413 Free PMC article. - The combined effects of arteriosclerosis and diabetes on cardiovascular disease risk.
Wang J, Yin MJ, Zheng JW, Fang H, Qin XY, Wang F, Wu SL, Meng SQ. Wang J, et al. Intern Emerg Med. 2024 Mar;19(2):365-375. doi: 10.1007/s11739-023-03478-3. Epub 2023 Dec 1. Intern Emerg Med. 2024. PMID: 38036801 - Usefulness of the Montreal Cognitive Assessment in Older Adults With Type 1 Diabetes.
Choe J, Kudrna R, Fonseca LM, Chaytor NS. Choe J, et al. Diabetes Spectr. 2023 Fall;36(4):385-390. doi: 10.2337/ds23-0012. Epub 2023 Sep 8. Diabetes Spectr. 2023. PMID: 37982060 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical